X-group (possible homology)

3010 C-terminal subdomain in Lon-related proteases catalytic domains

Ligands and drugs

821
Member domains
98
with ligand contacts (≤ 4 Å)
11.9% of members
88
with DrugDomain annotations
10.7% of members
67
with a DrugBank compound
8.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

9
Proteins with classified ligands
6
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Organosulfur compounds20.211×not tested
Organic acids and derivatives61.44.37×not tested
Organic nitrogen compounds10.33.53×not tested
Homogeneous metal compounds34.40.69×not tested
Organic oxygen compounds11.80.57×not tested
Homogeneous non-metal compounds11.90.52×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00188BO2Bortezomib22
DB03345BMEMercaptoethanol5
DB00536GAIGuanidine4
DB00139SINSuccinic acid2
DB03904UREUrea1

Most frequently bound compounds

PDB ligandNameDomains in contact
BO2N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE31
4KZN-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide11
GAIGUANIDINE6
BMEBETA-MERCAPTOETHANOL5
CAmetalCALCIUM ION2
MGmetalMAGNESIUM ION2
NAmetalSODIUM ION2
SINSUCCINIC ACID2
UFYN-[(1R)-1-borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-D-phenylalaninamide2
UKS[(1R)-4-phenyl-1-{[N-(pyrazine-2-carbonyl)-D-norvalyl]amino}butyl]boronic acid2
CIXN-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide1
CLCHLORIDE ION1
SLAOmuralide, open form1
UREUREA1